Medical and pharmacological direct costs of a 9-week smoking cessation programme.

Détails

ID Serval
serval:BIB_F149E0CA4BF4
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Medical and pharmacological direct costs of a 9-week smoking cessation programme.
Périodique
European Journal of Preventive Cardiology
Auteur(s)
Wasserfallen J.B., Digon P., Cornuz J.
ISSN
2047-4873, 2047-4881 (Electronic)
ISSN-L
2047-4873
Statut éditorial
Publié
Date de publication
2012
Volume
19
Numéro
3
Pages
565-70
Langue
anglais
Résumé
Background: Medical and pharmacological direct costs of cigarette smoking cessation programmes are not covered by health insurance in several countries despite documented cost-effectiveness. Design: prospective cost identification study of a 9-week programme in Switzerland. Methods: A total of 481 smokers were followed-up for 9 weeks. Socio-demographic characteristics, number of outpatient visits, dosage and frequency of use of nicotine replacement therapy (NRT) as well as date of relapse were prospectively collected. Individual cost of care until relapse or programme end as well as cost per week of follow-up were computed. Comparisons were carried out between the groups with or without relapse at the end of the programme. Results: Of the 209 men and 272 women included, 347 patients (72%) finished the programme. Among them, 240 patients (70%) succeeded in quitting and 107 patients (30%) relapsed. As compared with the group relapsing by the end of the programme, the group succeeding in quitting was more often living in a couple (68% vs. 55%, p = 0.029). Their mean weekly costs of visits were higher (CHF 81.2 ± 6.1 vs. 78.4 ± 7.6, p = 0.001), while their mean weekly costs for NRT were similar (CHF 24.2 ± 12.6 vs. 25.4 ± 15.9, p = 0.711). Mean total costs per week were similar (CHF 105.4 ± 15.4 vs. 103.8 ± 19.4, p = 0.252). More intensive NRT at week 4 increased the probability not to relapse at the end of the programme. Conclusions: Over 9 weeks, medical and pharmacological costs of stopping smoking are low. Good medical and social support as well as adequate NRT seem to play a role in successful quitting.
Pubmed
Web of science
Création de la notice
08/09/2011 21:22
Dernière modification de la notice
03/03/2018 22:38
Données d'usage